Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.1K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

540
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
540
Pulmonary Function Tests01:25

Pulmonary Function Tests

438
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
438
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

914
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
914
Factors Affecting Pulmonary Ventilation01:19

Factors Affecting Pulmonary Ventilation

1.7K
Besides the pressure difference between the external environment and the lungs, the airflow rate and ease of pulmonary ventilation are also influenced by three other factors: surface tension of the fluid in the alveoli, compliance of the lungs, and airway resistance.
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
1.7K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

2.6K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Turning the Air Black: Reflections on a year of environmental rollbacks.

American journal of respiratory and critical care medicine·2026
Same authorSame journal

Acute exacerbation in fibrotic interstitial lung disease: An International Working Group Report.

American journal of respiratory and critical care medicine·2026
Same author

FIBRONEER-ILD: taking a second look at the data.

The European respiratory journal·2026
Same author

Pulmonary fibrosis after COVID-19 is characterized by airway abnormalities and elevated club cell secretory protein-16.

JCI insight·2026
Same author

Geographical, institutional and workplace variability in genetic evaluation, screening practices, multidisciplinary care, and lung transplantation management for familial interstitial lung disease.

BMC pulmonary medicine·2026
Same author

Prevalence, detection, and trajectory of combined pulmonary fibrosis and emphysema.

Chest·2026

Related Experiment Video

Updated: Sep 19, 2025

Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters
05:18

Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters

Published on: July 12, 2024

400

Particulate Matter Associations with Lung Function in Pulmonary Sarcoidosis.

Sharon E Kim1, Deborah Assayag2, Matthew Broerman3

  • 1School of Medicine and.

American Journal of Respiratory and Critical Care Medicine
|June 18, 2025
PubMed
Summary

Exposure to fine particulate matter (PM2.5) is linked to worse lung function and faster decline in sarcoidosis patients, especially in areas with higher pollution. This highlights environmental disparities in disease progression.

Keywords:
PM2.5air pollutionlung functionparticulate mattersarcoidosis

More Related Videos

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

545
Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
08:17

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

11.1K

Related Experiment Videos

Last Updated: Sep 19, 2025

Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters
05:18

Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters

Published on: July 12, 2024

400
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

545
Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
08:17

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

11.1K

Area of Science:

  • Environmental Health
  • Pulmonology
  • Epidemiology

Background:

  • Sarcoidosis frequently affects the lungs, with environmental factors implicated in its incidence.
  • The impact of specific environmental exposures, like air pollution, on sarcoidosis clinical outcomes is not well understood.

Purpose of the Study:

  • To investigate the association between ambient particulate matter ≤2.5µm (PM2.5) exposure and lung function in patients with pulmonary sarcoidosis.
  • To determine if PM2.5 influences the rate of lung function decline over time.

Main Methods:

  • Utilized satellite-derived measurements of PM2.5, matched to patient addresses for 5-year pre-enrollment exposure assessment.
  • Employed linear models for baseline lung function (FEV1, FVC, DLCO) and linear mixed-effects models for annual lung function change.
  • Analyzed data from two prospective cohorts of non-smoking adults with diagnosed pulmonary sarcoidosis.

Main Results:

  • Higher PM2.5 exposure in the U.S. cohort (12.3µg/m3) compared to the Canadian cohort (8.0µg/m3).
  • Each 1µg/m3 increase in PM2.5 correlated with lower baseline FEV1 and FVC in the U.S. cohort (p<0.05).
  • PM2.5 and its constituents (sulfate, nitrate, ammonium) were linked to accelerated decline in FEV1, FVC, and DLCO in the U.S. cohort.

Conclusions:

  • Elevated PM2.5 exposure is associated with increased pulmonary sarcoidosis severity and disease progression.
  • Environmental exposure disparities significantly impact sarcoidosis outcomes.
  • Air quality interventions may be crucial for managing sarcoidosis progression.